We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+2.99%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$4.36B
AUM Growth
+$1.42B
Cap. Flow
+$2.09B
Cap. Flow %
47.88%
Top 10 Hldgs %
44.57%
Holding
147
New
40
Increased
52
Reduced
12
Closed
36

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$86.1M
2
TJX icon
TJX Companies
TJX
+$75.5M
3
TVTX icon
Travere Therapeutics
TVTX
+$65.1M
4
AMZN icon
Amazon
AMZN
+$63.1M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$52.3M

Top Sells

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$45.4M
2
ORLY icon
O'Reilly Automotive
ORLY
+$41M
3
ULTA icon
Ulta Beauty
ULTA
+$39.7M
4
FIVE icon
Five Below
FIVE
+$38M
5
FTDR icon
Frontdoor
FTDR
+$32.9M

Sector Composition

Rank Sector Weight
1 Healthcare 46.59%
2 Consumer Staples 10.1%
3 Consumer Discretionary 9.65%
4 Technology 2.31%
5 Industrials 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$793M 18.2%
2,000,000
+1,989,000
+18,082% +$767M
IWM icon
2
PUT
iShares Russell 2000 ETF
IWM
$80.9B
$442M 10.15%
2,000,000
+1,985,000
+13,233% +$433M
AVTX icon
3
Avalo Therapeutics
AVTX
$976M
$98.6M 2.26%
11,331
+868
+8% +$8.2M
BMY icon
4
Bristol-Myers Squibb
BMY
$127B
$94.7M 2.17%
1,500,000
+464,000
+45% +$28.9M
MRTX
5
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$91.8M 2.11%
536,000
+264,000
+97% +$52.3M
SUPN icon
6
Supernus Pharmaceuticals
SUPN
$2.68B
$89.3M 2.05%
3,412,000
+292,000
+9% +$8.17M
VRTX icon
7
Vertex Pharmaceuticals
VRTX
$121B
$84.2M 1.93%
+392,000
New +$86.1M
INCY icon
8
Incyte
INCY
$23.5B
$83.9M 1.93%
1,032,000
+354,000
+52% +$30.2M
REGN icon
9
Regeneron Pharmaceuticals
REGN
$68.8B
$82.8M 1.9%
175,000
+43,000
+33% +$20.9M
ENTA icon
10
Enanta Pharmaceuticals
ENTA
$372M
$81.3M 1.87%
1,648,000
+292,000
+22% +$14.6M
BIIB icon
11
Biogen
BIIB
$29.9B
$80.6M 1.85%
288,000
+30,000
+12% +$8.09M
AMZN icon
12
Amazon
AMZN
$2.5T
$77.4M 1.78%
500,000
+398,000
+390% +$63.1M
TJX icon
13
TJX Companies
TJX
$170B
$74.6M 1.71%
+1,128,122
New +$75.5M
BHVN
14
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$68.3M 1.57%
1,000,000
+428,000
+75% +$34.6M
PTCT icon
15
PTC Therapeutics
PTCT
$6.37B
$66.1M 1.52%
1,396,000
+680,000
+95% +$40.4M
ALKS icon
16
Alkermes
ALKS
$8.82B
$65.8M 1.51%
3,524,000
+1,308,000
+59% +$26.8M
MDT icon
17
Medtronic
MDT
$107B
$63.3M 1.45%
536,000
+280,000
+109% +$32.8M
BLUE
18
DELISTED
bluebird bio
BLUE
$59.2M 1.36%
151,621
+83,839
+124% +$41.3M
TVTX icon
19
Travere Therapeutics
TVTX
$5.33B
$58.8M 1.35%
+2,356,000
New +$65.1M
LNTH icon
20
Lantheus
LNTH
$6.82B
$57.7M 1.32%
2,700,000
-2,500,000
-48% -$45.4M
WMT icon
21
Walmart Inc
WMT
$871B
$57.4M 1.32%
1,266,804
+156,129
+14% +$7.23M
VNDA icon
22
Vanda Pharmaceuticals
VNDA
$312M
$57M 1.31%
3,796,000
-1,603,277
-30% -$26M
ZYME icon
23
Zymeworks
ZYME
$1.68B
$52.1M 1.2%
1,650,000
+1,200,000
+267% +$48.8M
UNH icon
24
UnitedHealth
UNH
$382B
$50.6M 1.16%
136,000
+36,000
+36% +$12.5M
AAP icon
25
Advance Auto Parts
AAP
$3.37B
$50.2M 1.15%
+273,469
New +$45.9M
1
2 3 4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q1 2021 Portfolio in Review

As of Q1 2021, Armistice Capital held 147 positions worth $4.36B, up 48% from $2.94B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Armistice Capital deployed $2.09B of net new capital in Q1 2021, opening 40 new positions and adding to 52 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 392,000 shares worth $84.2M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 48% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Lantheus, an estimated $45.4M trimmed.

  • Armistice Capital's largest Q1 2021 buy was Vertex Pharmaceuticals: 392,000 shares worth $84.2M.
  • Armistice Capital added most to Amazon in Q1 2021, an estimated $63.1M increase.
  • Armistice Capital's biggest Q1 2021 reduction was Lantheus, cutting an estimated $45.4M.
  • Armistice Capital fully exited O'Reilly Automotive in Q1 2021, selling an estimated $41M.
  • Armistice Capital's ten largest holdings make up 45% of its $4.36B portfolio in Q1 2021.
  • Armistice Capital opened 40 new positions and closed 36 in Q1 2021.
  • Armistice Capital's portfolio value rose 48% quarter-over-quarter to $4.36B.

Based on Armistice Capital's 13F filing for Q1 2021, filed 17 May 2021.